Related Experiment Video
Updated: Jun 14, 2025
Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting
Published on: March 25, 2019
miRNA-based electrochemical biosensors for ovarian cancer
Saber Rouhi1, Hassan Ghasemi2, Mehdi Alizadeh3
1Resident of Large Animal Internal Medicine, Department of Clinical Sciences, School of Veterinary Medicine, Shiraz University, Iran.
Abstract:
Ovarian cancer, a prevalent and deadly cancer among women, presents a significant challenge for early detection due to its heterogeneous nature. MicroRNAs, short non-coding regulatory RNA fragments, play a role in various cellular processes. Aberrant expression of these microRNAs has been observed in the carcinogenesis-related processes of many cancer types. Numerous studies highlight the critical role of microRNAs in the initiation and progression of ovarian cancer. Given their clinical importance and predictive value, there has been considerable interest in developing simple, prompt, and sensitive miRNA biosensor strategies. Among these, electrochemical sensors have demonstrated advantageous characteristics such as simplicity, sensitivity, low cost, and scalability. These microRNA-based electrochemical biosensors are valuable tools for early detection and point-of-care applications. This article discusses the potential role of microRNAs in ovarian cancer and recent advances in the development of electrochemical biosensors for miRNA detection in ovarian cancer samples.
Insights
Early detection of ovarian cancer is challenging. This study explores microRNAs and advanced electrochemical biosensors for sensitive and prompt detection, aiding in early diagnosis and point-of-care applications.
Area of Science:
- Biomedical Engineering
- Molecular Oncology
- Analytical Chemistry
Background:
- Ovarian cancer poses a significant challenge for early detection due to its complex and heterogeneous nature.
- MicroRNAs (miRNAs), short non-coding RNA fragments, are crucial regulators of cellular processes and their aberrant expression is linked to various cancers, including ovarian cancer.
- The critical role of miRNAs in ovarian cancer initiation and progression makes them promising biomarkers for early diagnosis.
Purpose of the Study:
- To review the role of microRNAs in the development and progression of ovarian cancer.
- To discuss recent advancements in electrochemical biosensor technologies for sensitive and specific miRNA detection.
- To highlight the potential of miRNA-based electrochemical biosensors for early ovarian cancer diagnosis and point-of-care applications.
Main Methods:
- Literature review focusing on microRNA biomarkers in ovarian cancer.
- Analysis of recent developments in electrochemical biosensor designs and detection mechanisms for miRNAs.
- Evaluation of the performance characteristics of various miRNA biosensor strategies.
Main Results:
- MicroRNAs are implicated in the initiation and progression of ovarian cancer, serving as potential diagnostic and prognostic biomarkers.
- Electrochemical biosensors offer a promising platform for miRNA detection due to their simplicity, sensitivity, low cost, and scalability.
- Recent advances have led to the development of highly sensitive and specific electrochemical biosensors for detecting specific miRNA signatures associated with ovarian cancer.
Conclusions:
- MicroRNAs hold significant potential as biomarkers for ovarian cancer, facilitating early detection and personalized treatment strategies.
- Electrochemical biosensors represent a valuable technological advancement for rapid, sensitive, and cost-effective miRNA detection.
- The integration of miRNA analysis with electrochemical biosensor technology offers a promising avenue for improved ovarian cancer diagnostics and point-of-care testing.
